Search research articles
Contact Us
Filters
Showing results (191-200 of 218) with videos related to
Page
of 22
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 13, 2022
Genetic characterization of advanced conjunctival melanoma and response to systemic treatment
Georg C Lodde, Philipp Jansen, Inga Möller, et al.
Cancers
|
February 27, 2026
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma
Michael Weichenthal, Dirk Debus, Lisa Zimmer, et al.
Journal for Immunotherapy of Cancer
|
June 10, 2022
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
Cindy Franklin, Peter Mohr, Leonie Bluhm, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2025
Sex-specific survival in advanced metastatic melanoma - a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG
Anna-Sophia Leven, Triinu Peters, Luisa Sophie Rajcsanyi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2019
Targeted Therapy in Advanced Melanoma With Rare <i>BRAF</i> Mutations
Christian Menzer, Alexander M Menzies, Matteo S Carlino, et al.
Data in Brief
|
November 25, 2022
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis
Leonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 26, 2022
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study
Leonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 21, 2023
Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma
Selina K Wong, Steven M Blum, Xiaopeng Sun, et al.
Cancer Discovery
|
November 23, 2013
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma
Eliezer M Van Allen, Nikhil Wagle, Antje Sucker, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2025
Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database
Christian Menzer, Susanne Dugas-Breit, Martin Dugas, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 218) with videos related to
Sort By:
Page
of 22
European Journal of Cancer (Oxford, England : 1990)
|
March 13, 2022
Genetic characterization of advanced conjunctival melanoma and response to systemic treatment
Georg C Lodde, Philipp Jansen, Inga Möller, et al.
Cancers
|
February 27, 2026
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma
Michael Weichenthal, Dirk Debus, Lisa Zimmer, et al.
Journal for Immunotherapy of Cancer
|
June 10, 2022
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
Cindy Franklin, Peter Mohr, Leonie Bluhm, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2025
Sex-specific survival in advanced metastatic melanoma - a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG
Anna-Sophia Leven, Triinu Peters, Luisa Sophie Rajcsanyi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2019
Targeted Therapy in Advanced Melanoma With Rare <i>BRAF</i> Mutations
Christian Menzer, Alexander M Menzies, Matteo S Carlino, et al.
Data in Brief
|
November 25, 2022
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis
Leonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 26, 2022
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study
Leonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 21, 2023
Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma
Selina K Wong, Steven M Blum, Xiaopeng Sun, et al.
Cancer Discovery
|
November 23, 2013
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma
Eliezer M Van Allen, Nikhil Wagle, Antje Sucker, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2025
Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database
Christian Menzer, Susanne Dugas-Breit, Martin Dugas, et al.
Page
of 22